Equities

SKAN Group AG

  • Add to watchlist
  • Add to portfolio
  • Add an alert

SKAN Group AG

Actions
  • Price (CHF)51.40
  • Today's Change0.300 / 0.59%
  • Shares traded10.24k
  • 1 Year change-34.36%
  • Beta0.8029
Data delayed at least 15 minutes, as of Feb 17 2026 13:14 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Financials data is unavailable for this security.

Inc stmt in CHFIncome statement in CHFView more

Year on year SKAN Group AG grew revenues 12.90% from 320.02m to 361.30m while net income improved 47.47% from 26.31m to 38.80m.
Gross margin74.38%
Net profit margin5.37%
Operating margin7.34%
Return on assets4.86%
Return on equity9.24%
Return on investment9.28%
More ▼

Cash flow in CHFView more

In 2024, cash reserves at SKAN Group AG fell by 31.41m. However, the company earned 46.70m from its operations for a Cash Flow Margin of 12.93%. In addition the company used 69.06m on investing activities and also paid 9.35m in financing cash flows.
Cash flow per share1.33
Price/Cash flow per share38.50
Book value per share7.88
Tangible book value per share7.71
More ▼

Balance sheet in CHFView more

SKAN Group AG has a Debt to Total Capital ratio of 5.18%, a higher figure than the previous year's 3.11%.
Current ratio1.15
Quick ratio0.524
Total debt/total equity0.0565
Total debt/total capital0.0518
More ▼

Growth rates in CHF

Year on year, both dividends per share and earnings per share excluding extraordinary items growth increased 14.29% and 47.47%, respectively. The positive trend in dividend payments is noteworthy since very few companies in the Medical Equipment & Supplies industry pay a dividend. Additionally, five year annualized earnings per share growth ranks below the industry average relative to its peers.
Div yield(5 year avg)--
Div growth rate (5 year)--
Payout ratio (TTM)55.59%
EPS growth(5 years)0.1249
EPS (TTM) vs
TTM 1 year ago
-49.58
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.